The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta‐analysis

Patients with locally advanced rectal cancer (LARC) are at tremendous risk of metastatic diseases. To improve the prognoses of LARC patients, the efficacy of adding targeted agents to neoadjuvant therapy has been investigated by many researchers but remains controversial. A literature search of rele...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Xi, Wu, Zhonghua, Gao, Peng, Shi, Jinxin, Sun, Jingxu, Guo, Zhexu, Wang, Zhenning, Song, Yongxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852374/
https://www.ncbi.nlm.nih.gov/pubmed/29464874
http://dx.doi.org/10.1002/cam4.1298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852374/
https://www.ncbi.nlm.nih.gov/pubmed/29464874
http://dx.doi.org/10.1002/cam4.1298

Ejemplares similares